Samsara BioCapital, LLC

Q3 2025 13F Holdings

  • Location
    palo alto, CA
  • Num holdings

    27

  • Value ($000)

    $765,929

  • Date Filed
    11/14/2025
  • Form type
    13F-HR
  • CIK
    0001744967
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
MLYS
MLYS

MINERALYS THERAPEUTICS INC

COM
603170101
$237.50 M
31 %

6,263,151

SRRK
SRRK

SCHOLAR ROCK HLDG CORP

COM
80706P103
$209.02 M
27 %

5,612,896

---

KALARIS THERAPEUTICS INC

COM
482929106
$66.17 M
9 %

11,448,081

---

SEPTERNA INC

COM
81734D104
$59.24 M
8 %

3,149,128

NGNE
NGNE

NEUROGENE INC

COM
64135M105
$29.76 M
4 %

1,717,127

ALMS
ALMS

ALUMIS INC

COM
022307102
$19.16 M
3 %

4,801,370

---

UPSTREAM BIO INC

COM
91678A107
$18.10 M
2 %

962,154

GOSS
GOSS

GOSSAMER BIO INC

COM
38341P102
$16.12 M
2 %

6,130,268

LENZ
LENZ

LENZ THERAPEUTICS INC

COM
52635N103
$15.98 M
2 %

343,012

AQST
AQST

AQUESTIVE THERAPEUTICS INC

COM
03843E104
$13.97 M
2 %

2,500,000

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 27